Technological Advances in Radiation Therapy for Prostate Cancer
- 131 Downloads
Radiation therapy (RT) for prostate cancer has made huge strides over the past two decades. The addition of image guidance has allowed radiation oncologists to ensure accurate delivery of increasingly precise radiation treatment plans using newer conformal therapy methods such as three-dimensional conformal RT, intensity-modulated RT, and proton beam RT. Regardless of the specific treatment technique, patients can depend on the treatment to target the moving prostate effectively while significantly sparing adjacent tissues, thereby reducing the morbidity of having to undergo prostate cancer therapy. This review summarizes the recent technical advances made in radiation dose delivery, including target volume definition, treatment planning, treatment delivery methods, and positional verification methods during RT.
KeywordsIntensity-modulated radiation therapy IMRT Image-guided radiation therapy IGRT Hypofractionated radiotherapy
No potential conflicts of interest relevant to this article were reported.
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
- 17.•• Kupelian P, Willoughby T, Mahadevan A, et al.: Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int J Radiat Oncol Biol Phys 2007, 67:1088–1098. This initial report of a multi-institutional trial demonstrates that the Calypso System is a clinically efficient and accurate localization method for positioning patients for prostate EBRT. The article offers the first data demonstrating that intrafraction motion occurs and can be corrected for with the Calypso System. Google Scholar
- 20.Li JS, Pollack A, Horwitz E: Clinical experience on localization and real-time tracking of the prostate during external radiotherapy using Calypso 4D localization system. Int J Radiat Oncol Biol Phys 2007, 69:S189.Google Scholar
- 43.Liao Y, Joiner M, Huang Y, Burmeister J: Hypofractionation: what does it mean for prostate cancer treatment? Int J Radiat Oncol Biol Phys 2009, 76:260–268.Google Scholar
- 45.•• Kupelian PA, Willoughby TR, Reddy CA, et al.: Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience. Int J Radiat Oncol Biol Phys 2007, 68:1424–1430. This is one of the largest studies demonstrating clinical outcomes after high-dose hypofractionated radiation therapy for localized prostate cancer that are comparable to outcomes achieved with standard radiation therapy regimens taking 2 weeks longer.Google Scholar
- 46.Pollack A, Li T, Buyyounouski M, et al.: Hypofractionation for prostate cancer: interim results of a randomized trial. Int J Radiat Oncol Biol Phys 2009, 75:S81–S82.Google Scholar
- 51.Miralbell R, Molla M, Rouzaud M, et al.: Hypofractionated boost to the dominant tumor region with intensity modulated stereotactic radiotherapy for prostate cancer: a sequential dose escalation pilot study. Int J Radiat Oncol Biol Phys 2009 Nov 10 (Epub ahead of print).Google Scholar
- 62.Mendenhall NP, Li Z, Morris CG, et al.: Early GI and GU toxicity in three prospective trials of proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2009, 75:S11–S12.Google Scholar
- 67.Zietman AL, Bae K, Rossi C, et al.: A phase III trial employing conformal photons with proton boost in early-stage prostate cancer: conventional dose (70.2 GyE) compared to high-dose irradiation (79.2 GyE): long-term updated analysis of Proton Radiation Oncology Group (PROG)/American College of Radiology (ACR) 95–09. Int J Radiat Oncol Biol Phys 2009, 75:S11.Google Scholar
- 68.ZIetman AL, DeSilvio ML, Slater JD: A prospective phase I/II study using proton beam radiation to deliver 82 GyE to men with localized prostate cancer: preliminary results of ACR 0312. Int J Radiat Oncol Biol Phys 2008, 72:S77.Google Scholar